Long-term Pegylated Interferon-α-2a Treatment for Chronic Hepatitis C in an Elderly Renal Transplant Recipient: Case Report and Literature Review

Combination treatment of pegylated interferon (PEG-IFN) plus ribavirin for renal transplant recipients (RTRs) with hepatitis C virus (HCV) infection remains controversial, as it has been associated with a high risk of rejection, resulting in graft loss and a reduction in patient survival. We present...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ming-Hua, Chen, Yong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602826/
https://www.ncbi.nlm.nih.gov/pubmed/25569669
http://dx.doi.org/10.1097/MD.0000000000000390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602826/
https://www.ncbi.nlm.nih.gov/pubmed/25569669
http://dx.doi.org/10.1097/MD.0000000000000390

Ejemplares similares